Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.
about
Viral quasispecies evolutionUnusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivityCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentPatterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor lovirideLethal mutagenesis of HIV with mutagenic nucleoside analogsCombinatorial approaches to the prevention and treatment of HIV-1 infectionFrequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of IndiaMultiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events.Estimate of the frequency of human immunodeficiency virus type 1 protease inhibitor resistance within unselected virus populations in vitro.Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses.Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus.Temporal and spatial analysis of Sin Nombre virus quasispecies in naturally infected rodentsPopulation genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisMinority variants of drug-resistant HIV.Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptaseNevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients.Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesisNonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture.Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.Characterization of a subtype D human immunodeficiency virus type 1 isolate that was obtained from an untreated individual and that is highly resistant to nonnucleoside reverse transcriptase inhibitors.Deep sequencing: becoming a critical tool in clinical virology.Viral quasispecies.
P2860
Q27013917-6704E52A-BB98-4E00-8604-5CE1480B127AQ27469694-BB2EE11B-5642-48DE-BD24-4F4E5A6D8E01Q27470003-3BAB9D80-AAC7-4B52-A6B6-BAC6FEBDF08AQ27488361-085C89FD-635E-4C48-BAF9-54490C963D0AQ28369293-1E82AA55-8D8C-4F89-A161-CB45277110AEQ28369649-EBAEBCB6-06B6-410B-9556-888E5150539FQ30400060-0750DA1D-616F-4FEB-870C-64D1353EA3C8Q33583299-A0E4BB2D-07D7-4CFE-ADF2-D5F7487965DEQ33592278-7079D7E7-165A-4397-A42D-21F5F789FAB8Q33643192-8A0D6C9A-75AD-4223-BECF-FCE82D56B643Q33690287-637F5B3F-017A-40A6-98AE-355F8E6A16F4Q33739249-A5D1508E-3480-49ED-A410-D224170C1FDAQ33755126-9A7CEA8F-C2A1-4C30-A76F-3617E8859770Q33782562-8C8571CC-2653-4E42-B43B-3077EC113AA8Q33785338-5E5A27F6-6EE6-4B8B-85D6-63BB9F3E6DB2Q33811164-1C39819A-53F4-4610-B3E7-411F56C2AB2CQ33819390-3DEEF32C-44DE-4B49-9E88-8EB2E1881B8DQ33823575-CB95C388-E951-4F1B-B2DF-F228AB8B53E8Q33843999-5ED1DA40-1098-4F9D-9961-8842E943A867Q33977153-67D9B237-75B1-4236-BB89-FC8F4A8961B3Q34010283-1E92986C-7DDF-458F-8109-503E1B543AA2Q34047780-EFF4F0C8-EAD4-48C0-9868-27AAA38BF027Q34110204-D1807245-A6EF-44C3-A241-92BCB45368C4Q34190672-D7E6B19F-7850-4E0B-86F0-346BA9DD0E0FQ35742512-7697B725-FA7F-4DF9-92B3-974FA5EF03F5Q35857907-1D03A6A5-501A-4B91-8A67-CBFE27F1FCDFQ35866696-9F6AC473-CC01-40AA-910C-8C4E55D73CBFQ35872364-91E7717C-808E-4879-B866-791D630D42E4Q35874788-EF3858BD-3485-4AF3-ADEF-7F5D0AA1B37AQ35878219-C8B66885-253B-4BB4-BD63-02F164B68A96Q35890953-F41429B6-9453-42DB-821F-80E4E9E5ED7DQ35907177-F6E6C1A9-7A40-4E7C-9C6A-C64BEDC24EE0Q36525566-11C544E3-684C-4242-AEA7-00085F6D74DCQ36723410-92126B32-05B7-4F6F-821E-DDA247972D0DQ37538534-606E9B12-8D4E-451D-8B87-23C787F6D1B8Q37574543-1C6CFAB6-61F4-44D6-8A4C-6EAE8A61535EQ37713470-B7122DDE-49F5-462B-BD3C-69D02D3E4EC2Q37730522-0BB80D50-88EE-4500-80DB-D397CC81E596Q38226696-5F197928-5987-4BDC-875B-FB04B20881C5Q38396578-A9A18188-0EBE-41C2-8117-E369C1E2C2D8
P2860
Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@ast
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@en
type
label
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@ast
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@en
prefLabel
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@ast
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@en
P2093
P2860
P1433
P1476
Pol gene quasispecies of human ...... ts undergoing no drug therapy.
@en
P2093
López-Galíndez C
Muñoz-Fernández MA
Quiñones-Mateu ME
P2860
P407
P577
1995-01-01T00:00:00Z